GlassScriptPhysician profile
Hamid Ghanbari
NPI 1912020553
$46,659.10
in general payments reported to CMS, 2019-2025
8 companies · $12K in 2025
The $12K reported for 2025 was more than what 83% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,125 · 2020: $6,475 · 2021: $87.11 · 2022: $5,385 · 2023: $5,306 · 2024: $12K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $3,851 · Food and Beverage: $1,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,025.00 |
| Travel and Lodging | $3,850.68 |
| Food and Beverage | $1,711.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22,222.78 | 2023-2025 | General - Therapies, Bodyguardian, Cds Broad Portfolio Offering |
| Preventice Services, LLC | $12,600.00 | 2019-2020 | |
| Abbott Laboratories | $5,385.06 | 2022 | |
| Medtronic, INC. | $4,976.68 | 2024 | |
| Impulse Dynamics (USA) INC. | $1,032.71 | 2024-2025 | Optimizer |
| Irhythm Technologies, INC. | $265.28 | 2023 | Zio Xt Patch |
| Biotronik INC. | $176.59 | 2021-2025 | Acticor 7 Vr-T Dx |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Ghanbari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.